Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


PINL:FRTX - Post by User

Post by EstevanOutsideron Feb 17, 2023 8:26pm
702 Views
Post# 35293224

RJ - Jeremy Macrea - PIPESTONE w/ outperform on update

RJ - Jeremy Macrea - PIPESTONE w/ outperform on update

from today's notes:

PIPE has had one of the largest growth profiles over the last few years as its Montney wells delivered exceptional returns. Its land base and many top quartile wells clearly put it in the foresight as a possible take-out candidate, especially as other Montney names looked to high-grade their asset base. We think that is partially why we’ve seen so much volatility in the name since last summer as investors debate the metrics of a takeout/merger, that was unexpectedly hit with a change in corporate strategy (and some mixed exploration well results). With the company seeing the technical revisions in its reserve report now, we believe much of this information is well disseminated and reflected in the valuation. Going forward, new well results in the lower Montney look again to be quite encouraging (at potentially 850+ bbls/d), but it will take a little longer to convince new shareholders of the success. Overall, we still believe there is good risk/reward as the company builds out its Pipestone play.

<< Previous
Bullboard Posts
Next >>